{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:50:53Z","timestamp":1791280253058,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.urolonc.2007.11.031","type":"journal-article","created":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T06:23:50Z","timestamp":1214893430000},"page":"341-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Role of neutrophils in BCG immunotherapy for bladder cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"Mark P.","family":"Simons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2007.11.031_bib1","first-page":"8","article-title":"Cancer statistics, 2004","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2007.11.031_bib2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0094-0143(21)00140-3","article-title":"Management of carcinoma in situ of the bladder: The case for surgical management","volume":"7","author":"Utz","year":"1980","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2007.11.031_bib3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"issue":"Suppl 3","key":"10.1016\/j.urolonc.2007.11.031_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000052388","article-title":"Urinary cytokines reflecting the immunological response in the urinary bladder to biological response modifiers: Their practical use","volume":"37","author":"Schamhart","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2007.11.031_bib5","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0022-5347(17)37668-1","article-title":"Intravesical Evans strain BCG therapy: Quantitative immunohistochemical analysis of the immune response within the bladder wall","volume":"147","author":"Prescott","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.11.031_bib6","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0022-5347(17)45922-2","article-title":"Histological parameters and pitfalls in the interpretation of bladder biopsies in Bacillus Calmette-Guerin treatment of superficial bladder cancer","volume":"135","author":"Lage","year":"1986","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.11.031_bib7","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1158\/0008-5472.CAN-04-0374","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand: A novel mechanism for Bacillus Calmette-Guerin-induced antitumor activity","volume":"64","author":"Ludwig","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2007.11.031_bib8","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1128\/IAI.00938-06","article-title":"Identification of the mycobacterial subcomponents involved in the release of tumor necrosis factor-related apoptosis-inducing ligand from human neutrophils","volume":"75","author":"Simons","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.urolonc.2007.11.031_bib9","first-page":"35","article-title":"History of BCG and its substrains","volume":"310","author":"Crispen","year":"1989","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.urolonc.2007.11.031_bib10","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0022-5347(17)38622-6","article-title":"Internalization of Bacille Calmette-Guerin by bladder tumor cells","volume":"145","author":"Becich","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.11.031_bib11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1128\/cdli.3.6.761-768.1996","article-title":"A novel method for monitoring Mycobacterium bovis BCG trafficking with recombinant BCG expressing green fluorescent protein","volume":"3","author":"Luo","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.urolonc.2007.11.031_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI114434","article-title":"Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa","volume":"85","author":"Kavoussi","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.urolonc.2007.11.031_bib13","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1128\/iai.62.6.2315-2321.1994","article-title":"Uroepithelial cells are part of a mucosal cytokine network","volume":"62","author":"Hedges","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.urolonc.2007.11.031_bib14","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0022-5347(01)64210-1","article-title":"Interleukin-8 expression in the urine after bacillus Calmette-Guerin therapy: A potential prognostic factor of tumor recurrence and progression","volume":"158","author":"Thalmann","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.11.031_bib15","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0022-5347(05)66983-2","article-title":"Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin","volume":"164","author":"Thalmann","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.11.031_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00326845","article-title":"Changes of the mucosal architecture and of urine cytology during BCG treatment","volume":"6","author":"Shapiro","year":"1988","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2007.11.031_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF01741603","article-title":"Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guerin","volume":"33","author":"de Boer","year":"1991","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.urolonc.2007.11.031_bib18","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1128\/iai.65.8.3451-3456.1997","article-title":"Role of epithelial interleukin-8 (IL-8) and neutrophil IL-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migration","volume":"65","author":"Godaly","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.urolonc.2007.11.031_bib19","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1182\/blood-2005-03-1327","article-title":"Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Gu\u00e9rin (BCG) results in the release of functional soluble TRAIL\/Apo-2L","volume":"106","author":"Kemp","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.urolonc.2007.11.031_bib20","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood-2003-08-2806","article-title":"IFN\u03b1-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL\/Apo-2 ligand) displaying apoptotic activity on leukemic cells","volume":"103","author":"Tecchio","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.urolonc.2007.11.031_bib21","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1158\/0008-5472.CAN-03-1808","article-title":"Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): A novel mechanism of antitumor effect by neutrophils","volume":"64","author":"Koga","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2007.11.031_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1189\/jlb.0805431","article-title":"Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL\/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators","volume":"79","author":"Cassatella","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.urolonc.2007.11.031_bib23","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1158\/0008-5472.CAN-06-1416","article-title":"Neutrophil granulocytes are required for effective bacillus Calmette-Guerin immunotherapy of bladder cancer and orchestrate local immune responses","volume":"66","author":"Suttmann","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2007.11.031_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.0019-2805.2003.01794.x","article-title":"Regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils","volume":"111","author":"Kamohara","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.urolonc.2007.11.031_bib25","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","article-title":"BCG immunotherapy of bladder cancer: 20 years on","volume":"353","author":"Alexandroff","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2007.11.031_bib26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1749-6632.1976.tb41699.x","article-title":"Immunotherapy of cancer with cell wall skeleton of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin: Experimental and clinical results","volume":"277","author":"Yamamura","year":"1976","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.urolonc.2007.11.031_bib27","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1517\/13543784.10.12.2157","article-title":"Therapeutic potential of mycobacterial cell wall-DNA complexes","volume":"10","author":"Filion","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.urolonc.2007.11.031_bib28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1083\/jcb.97.1.52","article-title":"Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: Translocation during activation","volume":"97","author":"Borregaard","year":"1983","journal-title":"J Cell Biol"},{"key":"10.1016\/j.urolonc.2007.11.031_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-5347(17)39366-7","article-title":"Elevations of cytokines interleukin-1, interleukin-2, and tumor necrosis factor in the urine of patients after intravesical Bacillus Calmette-Guerin immunotherapy","volume":"144","author":"Bohle","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.11.031_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2249.1995.tb05560.x","article-title":"Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after Bacillus Calmette-Guerin (BCG) immunotherapy","volume":"99","author":"Jackson","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.urolonc.2007.11.031_bib31","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.urolonc.2005.11.026","article-title":"Final results from a national multicenter Phase II trial of combination Bacillus Calmette-Guerin plus interferon \u03b1-2B for reducing recurrence of superficial bladder cancer","volume":"24","author":"Joudi","year":"2006","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2007.11.031_bib32","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.micinf.2003.09.008","article-title":"Neutrophil granules and secretory vesicles in inflammation","volume":"5","author":"Faurschou","year":"2003","journal-title":"Microbes Infect"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143907002980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143907002980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:53:21Z","timestamp":1761040401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143907002980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1078143907002980"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2007.11.031","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of neutrophils in BCG immunotherapy for bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2007.11.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}